Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Effects of an 8‐week high‐dose vitamin D supplementation on fatigue and neuropsychiatric manifestations in post‐COVID syndrome: A randomized controlled trial

Charoenporn et al., Psychiatry and Clinical Neurosciences, doi:10.1111/pcn.13716, TCTR20221013001
Jul 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,700+ studies for 94 treatments. c19early.org
RCT 80 long COVID patients showing benefits with high-dose vitamin D treatment. Participants received 60,000 IU vitamin D weekly or placebo for 8 weeks. The vitamin D group showed significant improvements in fatigue (CFQ score), anxiety (DASS-anxiety), and cognitive function (ACE score) compared to placebo. No significant differences were observed in sleep quality, depression, or inflammatory markers (IL-6, CRP).
Charoenporn et al., 28 Jul 2024, Double Blind Randomized Controlled Trial, placebo-controlled, peer-reviewed, 9 authors, trial TCTR20221013001.
This PaperVitamin DAll
{ 'indexed': {'date-parts': [[2024, 7, 29]], 'date-time': '2024-07-29T04:10:38Z', 'timestamp': 1722226238722}, 'reference-count': 86, 'publisher': 'Wiley', 'license': [ { 'start': { 'date-parts': [[2024, 7, 28]], 'date-time': '2024-07-28T00:00:00Z', 'timestamp': 1722124800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://onlinelibrary.wiley.com/termsAndConditions#vor'}], 'funder': [ { 'DOI': '10.13039/501100005790', 'name': 'Thammasat University', 'doi-asserted-by': 'publisher', 'award': ['2‐34/2565']}], 'content-domain': {'domain': ['onlinelibrary.wiley.com'], 'crossmark-restriction': True}, 'abstract': '<jats:sec><jats:title>Aim</jats:title><jats:p>This study evaluated the effectiveness of ' 'high‐dose vitamin D supplementation in alleviating fatigue and neuropsychiatric symptoms in ' 'post‐COVID syndrome.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>In ' 'an 8‐week, double‐blind, randomized, placebo‐controlled trial, 80 patients with post‐COVID ' 'fatigue or neuropsychiatric symptoms were enrolled. Participants were randomly assigned to ' 'receive either 60,000 IU of vitamin D weekly (<jats:italic>n</jats:italic>\u2009=\u200940) or ' 'a placebo (<jats:italic>n</jats:italic>\u2009=\u200940) for 8\u2009weeks. Clinical outcomes ' 'were assessed using the 11‐item Chalder Fatigue Scale (CFQ‐11); 21‐item Depression, Anxiety, ' "and Stress Scale (DASS‐21); Pittsburgh Sleep Quality Index (PSQI); Addenbrooke's Cognitive " 'Examination III (ACE); and Trail Making Test A and B (TMT‐A and TMT‐B). Baseline and 8‐week ' 'measurements of inflammatory markers, including interleukin 6 (IL‐6) and C‐reactive protein ' '(CRP), were also ' 'collected.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Significant ' 'improvements were found in the vitamin D group for CFQ (coefficient −3.5, ' '<jats:italic>P</jats:italic>\u2009=\u20090.024), DASS‐anxiety (−2.0, ' '<jats:italic>P</jats:italic>\u2009=\u20090.011), and ACE (2.1, ' '<jats:italic>P</jats:italic>\u2009=\u20090.012). No significant differences were observed in ' 'PSQI, DASS‐depression, TMT, IL‐6, or CRP levels. The incidence of adverse events was ' 'comparable between groups, with no serious adverse events ' 'reported.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>High‐dose ' 'vitamin D supplementation may benefit patients with post‐COVID syndrome by reducing fatigue, ' 'alleviating anxiety, and improving cognitive symptoms, with minimal side ' 'effects.</jats:p></jats:sec>', 'DOI': '10.1111/pcn.13716', 'type': 'journal-article', 'created': {'date-parts': [[2024, 7, 29]], 'date-time': '2024-07-29T03:54:44Z', 'timestamp': 1722225284000}, 'update-policy': 'http://dx.doi.org/10.1002/crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Effects of an 8‐week high‐dose vitamin D supplementation on fatigue and neuropsychiatric ' 'manifestations in post‐<scp>COVID</scp> syndrome: A randomized controlled trial', 'prefix': '10.1111', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-4187-2273', 'authenticated-orcid': False, 'given': 'Veevarin', 'family': 'Charoenporn', 'sequence': 'first', 'affiliation': [ {'name': 'Faculty of Medicine Thammasat University Pathumthani Thailand'}, { 'name': 'Department of Psychiatry Thammasat University Hospital ' 'Pathumthani Thailand'}, { 'name': 'Chulabhorn International College of Medicine Thammasat ' 'University Pathumthani Thailand'}]}, { 'given': 'Parunkul', 'family': 'Tungsukruthai', 'sequence': 'additional', 'affiliation': [ { 'name': 'Chulabhorn International College of Medicine Thammasat ' 'University Pathumthani Thailand'}]}, { 'given': 'Pitchapa', 'family': 'Teacharushatakit', 'sequence': 'additional', 'affiliation': [ { 'name': 'Medical student, Faculty of Medicine Thammasat University ' 'Pathumthani Thailand'}]}, { 'given': 'Sirashat', 'family': 'Hanvivattanakul', 'sequence': 'additional', 'affiliation': [ { 'name': 'Medical student, Faculty of Medicine Thammasat University ' 'Pathumthani Thailand'}]}, { 'given': 'Kusuma', 'family': 'Sriyakul', 'sequence': 'additional', 'affiliation': [ { 'name': 'Chulabhorn International College of Medicine Thammasat ' 'University Pathumthani Thailand'}]}, { 'given': 'Sophida', 'family': 'Sukprasert', 'sequence': 'additional', 'affiliation': [ { 'name': 'Chulabhorn International College of Medicine Thammasat ' 'University Pathumthani Thailand'}]}, { 'given': 'Chuntida', 'family': 'Kamalashiran', 'sequence': 'additional', 'affiliation': [ { 'name': 'Chulabhorn International College of Medicine Thammasat ' 'University Pathumthani Thailand'}]}, { 'given': 'Sucharat', 'family': 'Tungsukruthai', 'sequence': 'additional', 'affiliation': [ { 'name': 'Division of Health and Applied Sciences, Faculty of Science ' 'Prince of Songkla University Songkhla Thailand'}]}, { 'given': 'Thammanard', 'family': 'Charernboon', 'sequence': 'additional', 'affiliation': [ {'name': 'Faculty of Medicine Thammasat University Pathumthani Thailand'}, { 'name': 'Center of Excellence in Applied Epidemiology Thammasat ' 'University Pathumthani Thailand'}]}], 'member': '311', 'published-online': {'date-parts': [[2024, 7, 28]]}, 'reference': [ { 'key': 'e_1_2_11_2_1', 'doi-asserted-by': 'crossref', 'first-page': '1295', 'DOI': '10.3390/jpm12081295', 'article-title': 'Global challenges to public health care systems during the COVID‐19 ' 'pandemic: A review of pandemic measures and problems', 'volume': '12', 'author': 'Filip R', 'year': '2022', 'journal-title': 'J. Pers. Med.'}, { 'key': 'e_1_2_11_3_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1136/bmj-2022-071050', 'article-title': 'Post‐acute sequelae of covid‐19 six to 12 months after infection: ' 'Population based study', 'volume': '379', 'author': 'Peter RS', 'year': '2022', 'journal-title': 'BMJ'}, { 'key': 'e_1_2_11_4_1', 'doi-asserted-by': 'crossref', 'first-page': '16144', 'DOI': '10.1038/s41598-021-95565-8', 'article-title': 'More than 50 long‐term effects of COVID‐19: A systematic review and ' 'meta‐analysis', 'volume': '11', 'author': 'Lopez‐Leon S', 'year': '2021', 'journal-title': 'Sci. Rep.'}, { 'key': 'e_1_2_11_5_1', 'doi-asserted-by': 'crossref', 'first-page': '869', 'DOI': '10.1016/j.dsx.2021.04.007', 'article-title': 'Long COVID: An overview', 'volume': '15', 'author': 'Raveendran AV', 'year': '2021', 'journal-title': 'Diabetes Metab. Syndr.'}, { 'key': 'e_1_2_11_6_1', 'first-page': '14', 'article-title': 'Fatigue and neuropsychiatric manifestations of post‐acute sequelae of ' 'COVID‐19 (PASC): Examining the relationship with clinical and ' 'inflammatory markers', 'volume': '12', 'author': 'Charoenporn V', 'year': '2024', 'journal-title': 'Fatigue: Biomedicine, Health & Behavior.'}, { 'key': 'e_1_2_11_7_1', 'article-title': 'Psychological morbidities and fatigue in patients with confirmed ' 'COVID‐19 during disease outbreak: Prevalence and associated ' 'biopsychosocial risk factors', 'author': 'Qi R', 'year': '2020', 'journal-title': 'medRxiv.'}, { 'key': 'e_1_2_11_8_1', 'doi-asserted-by': 'crossref', 'first-page': '416', 'DOI': '10.1016/S2215-0366(21)00084-5', 'article-title': '6‐month neurological and psychiatric outcomes in 236 379 survivors of ' 'COVID‐19: A retrospective cohort study using electronic health records', 'volume': '8', 'author': 'Taquet M', 'year': '2021', 'journal-title': 'Lancet Psychiatry'}, { 'key': 'e_1_2_11_9_1', 'doi-asserted-by': 'crossref', 'first-page': '363', 'DOI': '10.3892/etm.2022.11290', 'article-title': 'Long COVID and neuropsychiatric manifestations (review)', 'volume': '23', 'author': 'Efstathiou V', 'year': '2022', 'journal-title': 'Exp. Ther. Med.'}, { 'key': 'e_1_2_11_10_1', 'doi-asserted-by': 'crossref', 'first-page': '84', 'DOI': '10.1111/pcn.13508', 'article-title': 'Neuropsychiatric aspects of long COVID: A comprehensive review', 'volume': '77', 'author': 'Kubota T', 'year': '2023', 'journal-title': 'Psychiatry Clin. Neurosci.'}, { 'key': 'e_1_2_11_11_1', 'doi-asserted-by': 'crossref', 'first-page': '220', 'DOI': '10.1016/S0140-6736(20)32656-8', 'article-title': '6‐month consequences of COVID‐19 in patients discharged from hospital: ' 'A cohort study', 'volume': '397', 'author': 'Huang C', 'year': '2021', 'journal-title': 'Lancet'}, { 'key': 'e_1_2_11_12_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/braincomms/fcab297', 'article-title': 'Persistent neuropsychiatric symptoms after COVID‐19: A systematic ' 'review and meta‐analysis', 'volume': '4', 'author': 'Badenoch JB', 'year': '2022', 'journal-title': 'Brain Commun.'}, { 'key': 'e_1_2_11_13_1', 'doi-asserted-by': 'crossref', 'first-page': '41', 'DOI': '10.1111/pcn.13306', 'article-title': 'A systematic review and meta‐analysis of the mental health symptoms ' 'during the Covid‐19 pandemic in Southeast Asia', 'volume': '76', 'author': 'Pappa S', 'year': '2022', 'journal-title': 'Psychiatry Clin. Neurosci.'}, { 'key': 'e_1_2_11_14_1', 'doi-asserted-by': 'crossref', 'first-page': '165', 'DOI': '10.1017/neu.2021.13', 'article-title': 'Inflammatory neuropsychiatric disorders and COVID‐19 neuroinflammation', 'volume': '33', 'author': 'Helmeste D', 'year': '2021', 'journal-title': 'Acta Neuropsychiatr.'}, { 'key': 'e_1_2_11_15_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ajp.2022.103409', 'article-title': 'Long term neuropsychiatric consequences in COVID‐19 survivors: ' 'Cognitive impairment and inflammatory underpinnings fifteen months ' 'after discharge', 'volume': '80', 'author': 'He D', 'year': '2023', 'journal-title': 'Asian J. Psychiatr.'}, { 'key': 'e_1_2_11_16_1', 'doi-asserted-by': 'crossref', 'first-page': '118', 'DOI': '10.1016/j.jpsychires.2021.11.031', 'article-title': 'One‐year mental health outcomes in a cohort of COVID‐19 survivors', 'volume': '145', 'author': 'Mazza MG', 'year': '2021', 'journal-title': 'J. Psychiatr. Res.'}, { 'key': 'e_1_2_11_17_1', 'doi-asserted-by': 'crossref', 'first-page': '737', 'DOI': '10.1080/23744235.2021.1924397', 'article-title': 'Long COVID or post‐COVID‐19 syndrome: Putative pathophysiology, risk ' 'factors, and treatments', 'volume': '53', 'author': 'Yong SJ', 'year': '2021', 'journal-title': 'Infect. Dis. (Lond).'}, { 'key': 'e_1_2_11_18_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ajp.2020.102066', 'article-title': 'COVID‐19 and mental health: A review of the existing literature', 'volume': '52', 'author': 'Rajkumar RP', 'year': '2020', 'journal-title': 'Asian J. Psychiatr.'}, { 'key': 'e_1_2_11_19_1', 'doi-asserted-by': 'crossref', 'first-page': '1012', 'DOI': '10.3390/brainsci10121012', 'article-title': 'Post‐COVID‐19 fatigue: Potential contributing factors', 'volume': '10', 'author': 'Rudroff T', 'year': '2020', 'journal-title': 'Brain Sci.'}, { 'key': 'e_1_2_11_20_1', 'doi-asserted-by': 'crossref', 'first-page': '3484', 'DOI': '10.1016/j.neuron.2022.10.006', 'article-title': 'The neurobiology of long COVID', 'volume': '110', 'author': 'Monje M', 'year': '2022', 'journal-title': 'Neuron'}, { 'key': 'e_1_2_11_21_1', 'doi-asserted-by': 'crossref', 'first-page': '125', 'DOI': '10.1111/pcn.13514', 'article-title': 'Chronic fatigue and affective symptoms in acute and long COVID are ' 'attributable to immune‐inflammatory pathways', 'volume': '77', 'author': 'Almulla AF', 'year': '2023', 'journal-title': 'Psychiatry Clin. Neurosci.'}, { 'key': 'e_1_2_11_22_1', 'doi-asserted-by': 'crossref', 'first-page': '111', 'DOI': '10.3390/nu5010111', 'article-title': 'Vitamin D ‐ effects on skeletal and extraskeletal health and the need ' 'for supplementation', 'volume': '5', 'author': 'Wacker M', 'year': '2013', 'journal-title': 'Nutrients'}, { 'key': 'e_1_2_11_23_1', 'doi-asserted-by': 'crossref', 'first-page': '26', 'DOI': '10.1210/jc.2008-1454', 'article-title': 'Nonclassic actions of vitamin D', 'volume': '94', 'author': 'Bikle D', 'year': '2009', 'journal-title': 'J. Clin. Endocrinol. Metab.'}, { 'key': 'e_1_2_11_24_1', 'doi-asserted-by': 'crossref', 'first-page': '482', 'DOI': '10.1016/j.coph.2010.04.001', 'article-title': 'Vitamin D: Modulator of the immune system', 'volume': '10', 'author': 'Baeke F', 'year': '2010', 'journal-title': 'Curr. Opin. Pharmacol.'}, { 'key': 'e_1_2_11_25_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1136/bmj.i6583', 'article-title': 'Vitamin D supplementation to prevent acute respiratory tract ' 'infections: Systematic review and meta‐analysis of individual ' 'participant data', 'volume': '356', 'author': 'Martineau AR', 'year': '2017', 'journal-title': 'BMJ'}, { 'key': 'e_1_2_11_26_1', 'doi-asserted-by': 'crossref', 'first-page': '186', 'DOI': '10.1007/s11914-022-00732-z', 'article-title': 'Regulation of immune function', 'volume': '20', 'author': 'Bikle DD', 'year': '2022', 'journal-title': 'Curr. Osteoporos. Rep.'}, { 'key': 'e_1_2_11_27_1', 'doi-asserted-by': 'crossref', 'first-page': '3512', 'DOI': '10.3390/nu12113512', 'article-title': 'Vitamin D3 as potential treatment adjuncts for COVID‐19', 'volume': '12', 'author': 'Malaguarnera L', 'year': '2020', 'journal-title': 'Nutrients'}, { 'key': 'e_1_2_11_28_1', 'doi-asserted-by': 'crossref', 'first-page': '1187163', 'DOI': '10.3389/fmed.2023.1187163', 'article-title': 'ME/CFS and long COVID share similar symptoms and biological ' 'abnormalities: Road map to the literature', 'volume': '10', 'author': 'Komaroff AL', 'year': '2023', 'journal-title': 'Front. Med. (Lausanne).'}, { 'key': 'e_1_2_11_29_1', 'doi-asserted-by': 'crossref', 'first-page': '221', 'DOI': '10.3390/nu16020221', 'article-title': 'Vitamin D and its role on the fatigue mitigation: A narrative review', 'volume': '16', 'author': 'Di Molfetta IV', 'year': '2024', 'journal-title': 'Nutrients'}, { 'key': 'e_1_2_11_30_1', 'doi-asserted-by': 'crossref', 'first-page': '166', 'DOI': '10.3109/02813432.2010.505407', 'article-title': 'Vitamin D status in patients with musculoskeletal pain, fatigue and ' 'headache: A cross‐sectional descriptive study in a multi‐ethnic general ' 'practice in Norway', 'volume': '28', 'author': 'Knutsen KV', 'year': '2010', 'journal-title': 'Scand. J. Prim. Health Care'}, { 'key': 'e_1_2_11_31_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1097/MD.0000000000005353', 'article-title': 'Effect of vitamin D3 on self‐perceived fatigue: A double‐blind ' 'randomized placebo‐controlled trial', 'volume': '95', 'author': 'Nowak A', 'year': '2016', 'journal-title': 'Medicine (Baltimore).'}, { 'key': 'e_1_2_11_32_1', 'doi-asserted-by': 'crossref', 'first-page': '71', 'DOI': '10.1007/s11154-011-9200-6', 'article-title': 'Relevance of vitamin D in muscle health', 'volume': '13', 'author': 'Bischoff‐Ferrari HA', 'year': '2012', 'journal-title': 'Rev. Endocr. Metab. Disord.'}, { 'key': 'e_1_2_11_33_1', 'doi-asserted-by': 'crossref', 'first-page': '46', 'DOI': '10.1016/j.psychres.2015.02.016', 'article-title': 'Associations between vitamin D levels and depressive symptoms in ' 'healthy young adult women', 'volume': '227', 'author': 'Kerr DC', 'year': '2015', 'journal-title': 'Psychiatry Res.'}, { 'key': 'e_1_2_11_34_1', 'doi-asserted-by': 'crossref', 'first-page': '1146', 'DOI': '10.1210/jc.2011-2218', 'article-title': 'IOM committee members respond to Endocrine Society vitamin D guideline', 'volume': '97', 'author': 'Rosen CJ', 'year': '2012', 'journal-title': 'J. Clin. Endocrinol. Metab.'}, { 'key': 'e_1_2_11_35_1', 'doi-asserted-by': 'crossref', 'first-page': 'e107', 'DOI': '10.7861/clinmed.2020-0301', 'article-title': 'Does vitamin D deficiency increase the severity of COVID‐19?', 'volume': '20', 'author': 'Weir EK', 'year': '2020', 'journal-title': 'Clin. Med. (Lond.)'}, { 'key': 'e_1_2_11_36_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.metabol.2020.154322', 'article-title': 'Commentary. Eliminating vitamin D deficiency during the COVID‐19 ' 'pandemic: A call to action', 'volume': '112', 'author': 'Manson JE', 'year': '2020', 'journal-title': 'Metabolism'}, { 'key': 'e_1_2_11_37_1', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fimmu.2022.967215', 'article-title': 'Could vitamin D supplementation play a role against COVID‐19?', 'volume': '13', 'author': 'Li B', 'year': '2022', 'journal-title': 'Front. Immunol.'}, { 'key': 'e_1_2_11_38_1', 'doi-asserted-by': 'crossref', 'first-page': '1373', 'DOI': '10.1016/j.jiph.2020.06.021', 'article-title': 'Role of vitamin D in preventing of COVID‐19 infection, progression and ' 'severity', 'volume': '13', 'author': 'Ali N', 'year': '2020', 'journal-title': 'J. Infect. Public Health'}, { 'key': 'e_1_2_11_39_1', 'doi-asserted-by': 'crossref', 'first-page': '154', 'DOI': '10.1002/jmv.27294', 'article-title': 'Analysis of serum cytokine and protective vitamin D levels in severe ' 'cases of COVID‐19', 'volume': '94', 'author': 'Bayraktar N', 'year': '2022', 'journal-title': 'J. Med. Virol.'}, { 'key': 'e_1_2_11_40_1', 'doi-asserted-by': 'crossref', 'first-page': '2198', 'DOI': '10.1016/j.clnu.2023.09.008', 'article-title': 'The role of vitamin D in the prevention and treatment of SARS‐CoV‐2 ' 'infection: A meta‐analysis of randomized controlled trials', 'volume': '42', 'author': 'Meng J', 'year': '2023', 'journal-title': 'Clin. Nutr.'}, { 'key': 'e_1_2_11_41_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.lfs.2022.120464', 'article-title': 'COVID‐19 and neurological sequelae: Vitamin D as a possible ' 'neuroprotective and/or neuroreparative agent', 'volume': '297', 'author': 'Menéndez SG', 'year': '2022', 'journal-title': 'Life Sci.'}, { 'key': 'e_1_2_11_42_1', 'doi-asserted-by': 'crossref', 'first-page': '1625', 'DOI': '10.3390/nu14081625', 'article-title': 'Vitamin D: A role also in long COVID‐19?', 'volume': '14', 'author': 'Barrea L', 'year': '2022', 'journal-title': 'Nutrients'}, { 'key': 'e_1_2_11_43_1', 'doi-asserted-by': 'crossref', 'first-page': '215', 'DOI': '10.1007/s13668-023-00471-2', 'article-title': 'A narrative review on the potential role of Vitamin D(3) in the ' 'prevention, protection, and disease mitigation of acute and long ' 'COVID‐19', 'volume': '12', 'author': 'Moukayed M', 'year': '2023', 'journal-title': 'Curr. Nutr. Rep.'}, { 'key': 'e_1_2_11_44_1', 'doi-asserted-by': 'crossref', 'first-page': 'e1106', 'DOI': '10.1210/clinem/dgad207', 'article-title': 'Low Vitamin D levels are associated with long COVID syndrome in ' 'COVID‐19 survivors', 'volume': '108', 'author': 'Filippo L', 'year': '2023', 'journal-title': 'J. Clin. Endocrinol. Metab.'}, { 'key': 'e_1_2_11_45_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.mad.2022.111684', 'article-title': 'Association between vitamin D status and physical performance in ' 'COVID‐19 survivors: Results from the Gemelli against COVID‐19 ' 'post‐acute care project', 'volume': '205', 'author': 'Galluzzo V', 'year': '2022', 'journal-title': 'Mech. Ageing Dev.'}, { 'key': 'e_1_2_11_46_1', 'doi-asserted-by': 'crossref', 'first-page': '7058', 'DOI': '10.3390/ijerph20227058', 'article-title': 'Effect of Vitamin D in long COVID patients', 'volume': '20', 'author': 'Hikmet RG', 'year': '2023', 'journal-title': 'Int. J. Environ. Res. Public Health'}, { 'key': 'e_1_2_11_47_1', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/nu12092775', 'article-title': 'Impact of Vitamin D deficiency on COVID‐19‐a prospective analysis from ' 'the CovILD registry', 'volume': '12', 'author': 'Pizzini A', 'year': '2020', 'journal-title': 'Nutrients'}, { 'key': 'e_1_2_11_48_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pone.0240784', 'article-title': 'Persistent fatigue following SARS‐CoV‐2 infection is common and ' 'independent of severity of initial infection', 'volume': '15', 'author': 'Townsend L', 'year': '2020', 'journal-title': 'PLoS One'}, { 'key': 'e_1_2_11_49_1', 'doi-asserted-by': 'crossref', 'first-page': '1911', 'DOI': '10.1210/jc.2011-0385', 'article-title': 'Evaluation, treatment, and prevention of vitamin D deficiency: An ' 'Endocrine Society clinical practice guideline', 'volume': '96', 'author': 'Holick MF', 'year': '2011', 'journal-title': 'J. Clin. Endocrinol. Metab.'}, { 'key': 'e_1_2_11_50_1', 'doi-asserted-by': 'crossref', 'first-page': '147', 'DOI': '10.1016/0022-3999(93)90081-P', 'article-title': 'Development of a fatigue scale', 'volume': '37', 'author': 'Chalder T', 'year': '1993', 'journal-title': 'J. Psychosom. Res.'}, { 'key': 'e_1_2_11_51_1', 'doi-asserted-by': 'crossref', 'first-page': '335', 'DOI': '10.1016/0005-7967(94)00075-U', 'article-title': 'The structure of negative emotional states: Comparison of the ' 'depression anxiety stress scales (DASS) with the Beck depression and ' 'anxiety inventories', 'volume': '33', 'author': 'Lovibond PF', 'year': '1995', 'journal-title': 'Behav. Res. Ther.'}, { 'key': 'e_1_2_11_52_1', 'doi-asserted-by': 'crossref', 'first-page': '193', 'DOI': '10.1016/0165-1781(89)90047-4', 'article-title': 'The Pittsburgh sleep quality index: A new instrument for psychiatric ' 'practice and research', 'volume': '28', 'author': 'Buysse DJ', 'year': '1989', 'journal-title': 'Psychiatry Res.'}, { 'key': 'e_1_2_11_53_1', 'first-page': 'S57', 'article-title': 'Reliability and validity of the Thai version of the Pittsburgh sleep ' 'quality index', 'volume': '97', 'author': 'Sitasuwan T', 'year': '2014', 'journal-title': 'J. Med. Assoc. Thai.'}, { 'key': 'e_1_2_11_54_1', 'doi-asserted-by': 'crossref', 'first-page': '242', 'DOI': '10.1159/000351671', 'article-title': "Validation of the Addenbrooke's cognitive examination III in " "frontotemporal dementia and Alzheimer's disease", 'volume': '36', 'author': 'Hsieh S', 'year': '2013', 'journal-title': 'Dement. Geriatr. Cogn. Disord.'}, { 'key': 'e_1_2_11_55_1', 'doi-asserted-by': 'crossref', 'first-page': '571', 'DOI': '10.4306/pi.2016.13.5.571', 'article-title': "The Thai version of the Addenbrooke's cognitive examination III", 'volume': '13', 'author': 'Charernboon T', 'year': '2016', 'journal-title': 'Psychiatry Investig.'}, { 'key': 'e_1_2_11_56_1', 'doi-asserted-by': 'crossref', 'first-page': '271', 'DOI': '10.2466/pms.1958.8.3.271', 'article-title': 'Validity of the trail making test as an indicator of organic brain ' 'damage', 'volume': '8', 'author': 'Reitan RM', 'year': '1958', 'journal-title': 'Percept. Mot. Skills'}, { 'key': 'e_1_2_11_57_1', 'doi-asserted-by': 'crossref', 'first-page': '235', 'DOI': '10.3390/brainsci11020235', 'article-title': 'Long‐lasting cognitive abnormalities after COVID‐19', 'volume': '11', 'author': 'Ferrucci R', 'year': '2021', 'journal-title': 'Brain Sci.'}, { 'key': 'e_1_2_11_58_1', 'doi-asserted-by': 'crossref', 'first-page': '74', 'DOI': '10.1186/s43066-021-00144-1', 'article-title': 'Long‐term clinical and biochemical residue after COVID‐19 recovery', 'volume': '11', 'author': 'Gameil MA', 'year': '2021', 'journal-title': 'Egypt Liver J.'}, { 'key': 'e_1_2_11_59_1', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fmed.2023.1085988', 'article-title': 'Biomarkers in long COVID‐19: A systematic review', 'volume': '10', 'author': 'Lai YJ', 'year': '2023', 'journal-title': 'Front. Med. (Lausanne).'}, { 'key': 'e_1_2_11_60_1', 'doi-asserted-by': 'crossref', 'first-page': '43', 'DOI': '10.1186/s40249-023-01086-z', 'article-title': 'Increased interleukin‐6 is associated with long COVID‐19: A systematic ' 'review and meta‐analysis', 'volume': '12', 'author': 'Yin JX', 'year': '2023', 'journal-title': 'Infect. Dis. Poverty'}, { 'key': 'e_1_2_11_61_1', 'doi-asserted-by': 'crossref', 'first-page': '550', 'DOI': '10.3389/fendo.2018.00550', 'article-title': 'Vitamin D toxicity‐a clinical perspective', 'volume': '9', 'author': 'Marcinowska‐Suchowierska E', 'year': '2018', 'journal-title': 'Front. Endocrinol. (Lausanne).'}, { 'key': 'e_1_2_11_62_1', 'doi-asserted-by': 'crossref', 'first-page': '172', 'DOI': '10.4103/2356-8062.200905', 'article-title': 'Surrogate markers for diagnosis of vitamin D deficiency', 'volume': '2', 'author': 'Boutros R', 'year': '2016', 'journal-title': 'Egyptian Journal of Obesity, Diabetes and Endocrinology.'}, { 'key': 'e_1_2_11_63_1', 'volume-title': 'Efficacy of Vitamin D3 in Symptomatic Improvement of Post COVID‐19 ' 'Fatigue Condition in Thai Elderly: Prospective, Double Blinded, ' "Randomized Controlled Trial [Master's Thesis on the Internet]", 'author': 'Lungkorn N', 'year': '2022'}, { 'key': 'e_1_2_11_64_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1002/brb3.1760', 'article-title': 'Vitamin D supplementation improves anxiety but not depression symptoms ' 'in patients with vitamin D deficiency', 'volume': '10', 'author': 'Zhu C', 'year': '2020', 'journal-title': 'Brain Behav.'}, { 'key': 'e_1_2_11_65_1', 'doi-asserted-by': 'crossref', 'first-page': '675', 'DOI': '10.1007/s13668-022-00441-0', 'article-title': 'Is Vitamin D important in anxiety or depression? What is the truth?', 'volume': '11', 'author': 'Akpınar Ş', 'year': '2022', 'journal-title': 'Curr. Nutr. Rep.'}, { 'key': 'e_1_2_11_66_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1155/2020/6097820', 'article-title': 'Low Vitamin D and its association with cognitive impairment and ' 'dementia', 'volume': '2020', 'author': 'Sultan S', 'year': '2020', 'journal-title': 'J. Aging Res.'}, { 'key': 'e_1_2_11_67_1', 'article-title': "The efficacy of Vitamin D supplementation in patients with Alzheimer's " 'disease in preventing cognitive decline: A systematic review', 'volume': '14', 'author': 'Chakkera M', 'year': '2022', 'journal-title': 'Cureus'}, { 'key': 'e_1_2_11_68_1', 'doi-asserted-by': 'crossref', 'first-page': '74', 'DOI': '10.4103/jpgm.JPGM_571_17', 'article-title': 'Efficacy of vitamin D supplementation in major depression: A ' 'meta‐analysis of randomized controlled trials', 'volume': '65', 'author': 'Vellekkatt F', 'year': '2019', 'journal-title': 'J. Postgrad. Med.'}, { 'key': 'e_1_2_11_69_1', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/nu14051076', 'article-title': 'Vitamin D Supplementation and sleep: A systematic review and ' 'meta‐analysis of intervention studies', 'volume': '14', 'author': 'Abboud M', 'year': '2022', 'journal-title': 'Nutrients'}, { 'key': 'e_1_2_11_70_1', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fnins.2021.670879', 'article-title': 'Vitamin D, depressive symptoms, and Covid‐19 pandemic', 'volume': '15', 'author': 'Ceolin G', 'year': '2021', 'journal-title': 'Front. Neurosci.'}, { 'key': 'e_1_2_11_71_1', 'doi-asserted-by': 'crossref', 'first-page': '1765', 'DOI': '10.3390/nu15071765', 'article-title': 'Vitamin D in depression: A potential bioactive agent to reduce suicide ' 'and suicide attempt risk', 'volume': '15', 'author': 'Somoza‐Moncada MM', 'year': '2023', 'journal-title': 'Nutrients'}, { 'key': 'e_1_2_11_72_1', 'doi-asserted-by': 'crossref', 'first-page': '3802', 'DOI': '10.3390/nu15173802', 'article-title': 'Neuroimmunological effect of Vitamin D on neuropsychiatric long COVID ' 'syndrome: A review', 'volume': '15', 'author': 'Chen TB', 'year': '2023', 'journal-title': 'Nutrients'}, { 'key': 'e_1_2_11_73_1', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/brainsci13040688', 'article-title': 'Mixed depression in the post‐COVID‐19 syndrome: Correlation between ' 'excitatory symptoms in depression and physical burden after COVID‐19', 'volume': '13', 'author': 'Simonetti A', 'year': '2023', 'journal-title': 'Brain Sci.'}, { 'key': 'e_1_2_11_74_1', 'doi-asserted-by': 'crossref', 'first-page': '2245', 'DOI': '10.3390/ijms19082245', 'article-title': 'Vitamin D in neurological diseases: A rationale for a pathogenic impact', 'volume': '19', 'author': 'Moretti R', 'year': '2018', 'journal-title': 'Int. J. Mol. Sci.'}, { 'key': 'e_1_2_11_75_1', 'doi-asserted-by': 'crossref', 'first-page': '779', 'DOI': '10.1111/jnc.15829', 'article-title': 'Vitamin D: A potent regulator of dopaminergic neuron differentiation ' 'and function', 'volume': '166', 'author': 'Pertile RAN', 'year': '2023', 'journal-title': 'J. Neurochem.'}, { 'key': 'e_1_2_11_76_1', 'doi-asserted-by': 'crossref', 'first-page': '19', 'DOI': '10.1186/s12263-018-0605-7', 'article-title': 'Optimal vitamin D spurs serotonin: 1,25‐dihydroxyvitamin D represses ' 'serotonin reuptake transport (SERT) and degradation (MAO‐A) gene ' 'expression in cultured rat serotonergic neuronal cell lines', 'volume': '13', 'author': 'Sabir MS', 'year': '2018', 'journal-title': 'Genes Nutr.'}, { 'key': 'e_1_2_11_77_1', 'doi-asserted-by': 'crossref', 'first-page': '66', 'DOI': '10.1159/000289049', 'article-title': 'Serotonin receptors and their function in sleep, anxiety disorders and ' 'depression', 'volume': '65', 'author': 'Leonard BE', 'year': '1996', 'journal-title': 'Psychother. Psychosom.'}, { 'key': 'e_1_2_11_78_1', 'doi-asserted-by': 'crossref', 'first-page': '249', 'DOI': '10.1007/s10787-023-01383-x', 'article-title': 'Pharmacological evaluation of vitamin D in COVID‐19 and long COVID‐19: ' 'Recent studies confirm clinical validation and highlight metformin to ' 'improve VDR sensitivity and efficacy', 'volume': '32', 'author': 'Gomaa AA', 'year': '2023', 'journal-title': 'Inflammopharmacology'}, { 'key': 'e_1_2_11_79_1', 'doi-asserted-by': 'crossref', 'first-page': '1079', 'DOI': '10.3390/medicina57101079', 'article-title': 'Effect of Vitamin D supplementation on muscle status in old patients ' 'recovering from COVID‐19 infection', 'volume': '57', 'author': 'Caballero‐García A', 'year': '2021', 'journal-title': 'Medicina (Kaunas)'}, { 'key': 'e_1_2_11_80_1', 'doi-asserted-by': 'crossref', 'first-page': '2170', 'DOI': '10.3390/nu13072170', 'article-title': 'Effects of a 2‐week 5000 IU versus 1000 IU Vitamin D3 supplementation ' 'on recovery of symptoms in patients with mild to moderate Covid‐19: A ' 'randomized clinical trial', 'volume': '13', 'author': 'Sabico S', 'year': '2021', 'journal-title': 'Nutrients'}, { 'key': 'e_1_2_11_81_1', 'first-page': '449', 'article-title': 'Serum vitamin D levels and inflammatory status in COVID‐19 patients', 'volume': '124', 'author': 'Arabadzhiyska D', 'year': '2023', 'journal-title': 'Bratisl. Lek. Listy'}, { 'key': 'e_1_2_11_82_1', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1159/000535302', 'article-title': 'Association of Vitamin D with severity and outcome of COVID‐19: ' 'Clinical and experimental evidence', 'volume': '16', 'author': 'Renieris G', 'year': '2023', 'journal-title': 'J. Innate Immun.'}, { 'key': 'e_1_2_11_83_1', 'doi-asserted-by': 'crossref', 'first-page': '55', 'DOI': '10.1186/s43166-022-00155-9', 'article-title': 'Serum vitamin D level in COVID‐19 patients and its correlation with ' 'disease severity', 'volume': '49', 'author': 'Morad CS', 'year': '2022', 'journal-title': 'Egypt. Rheumatol. Rehabil.'}, { 'key': 'e_1_2_11_84_1', 'article-title': 'The impact of Vitamin D supplementation on mortality rate and clinical ' 'outcomes of COVID‐19 patients: A systematic review and meta‐analysis', 'volume': '27', 'author': 'Nikniaz L', 'year': '2021', 'journal-title': 'Pharm. Sci.'}, { 'key': 'e_1_2_11_85_1', 'doi-asserted-by': 'crossref', 'first-page': '87', 'DOI': '10.1136/postgradmedj-2020-139065', 'article-title': 'Short term, high‐dose vitamin D supplementation for COVID‐19 disease: A ' 'randomised, placebo‐controlled, study (SHADE study)', 'volume': '98', 'author': 'Rastogi A', 'year': '2022', 'journal-title': 'Postgrad. Med. J.'}, { 'key': 'e_1_2_11_86_1', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.advnut.2023.09.016', 'article-title': 'Comparison of the effect of daily Vitamin D2 and Vitamin D3 ' 'supplementation on serum 25‐Hydroxyvitamin D concentration (Total ' '25(OH)D, 25(OH)D2, and 25(OH)D3) and importance of body mass index: A ' 'systematic review and meta‐analysis', 'volume': '15', 'author': 'Van den Heuvel EGHM', 'year': '2024', 'journal-title': 'Adv. Nutr.'}, { 'key': 'e_1_2_11_87_1', 'doi-asserted-by': 'crossref', 'first-page': '5387', 'DOI': '10.1210/jc.2004-0360', 'article-title': 'Vitamin D2 is much less effective than vitamin D3 in humans', 'volume': '89', 'author': 'Armas LA', 'year': '2004', 'journal-title': 'J. Clin. Endocrinol. Metab.'}], 'container-title': 'Psychiatry and Clinical Neurosciences', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13716', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 7, 29]], 'date-time': '2024-07-29T03:55:17Z', 'timestamp': 1722225317000}, 'score': 1, 'resource': {'primary': {'URL': 'https://onlinelibrary.wiley.com/doi/10.1111/pcn.13716'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 7, 28]]}, 'references-count': 86, 'alternative-id': ['10.1111/pcn.13716'], 'URL': 'http://dx.doi.org/10.1111/pcn.13716', 'relation': {}, 'ISSN': ['1323-1316', '1440-1819'], 'subject': [], 'container-title-short': 'Psychiatry Clin Neurosci', 'published': {'date-parts': [[2024, 7, 28]]}, 'assertion': [ { 'value': '2024-02-06', 'order': 0, 'name': 'received', 'label': 'Received', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2024-06-27', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2024-07-28', 'order': 3, 'name': 'published', 'label': 'Published', 'group': {'name': 'publication_history', 'label': 'Publication History'}}]}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit